- |||||||||| morphine sulphate / Generic mfg., hydromorphone hydrochloride / Generic mfg.
Trial completion date, Trial primary completion date: A Comparison Trial Between PCA and Epidural Analgesia for Pectus Excavatum Repair (clinicaltrials.gov) - Jan 30, 2020 P4, N=54, Terminated, Trial primary completion date: Dec 2019 --> Jun 2020 Trial completion date: Jan 2019 --> Oct 2019 | Trial primary completion date: Jan 2019 --> Apr 2019
- |||||||||| morphine sulphate / Generic mfg.
Enrollment change: Use of ACUPUNCTURE in Emergency Departement (clinicaltrials.gov) - Jan 30, 2020 P=N/A, N=300, Completed, Trial completion date: Jan 2019 --> Oct 2019 | Trial primary completion date: Jan 2019 --> Apr 2019 N=200 --> 300
- |||||||||| morphine sulphate / Generic mfg., gabapentin / Generic mfg., paracetamol / Generic mfg.
New trial, Surgery: Multimodal Pain Study in Free Flap Patients (clinicaltrials.gov) - Jan 29, 2020 P=N/A, N=166, Recruiting,
- |||||||||| methadone / Generic mfg.
Trial completion: MSCD: Methadone in Pediatric and Adult Sickle Cell Patients (clinicaltrials.gov) - Jan 22, 2020 P=N/A, N=47, Completed, Trial completion date: Feb 2020 --> Dec 2020 | Trial primary completion date: Sep 2019 --> Jul 2020 Recruiting --> Completed
- |||||||||| Sufenta (sufentanil) / Akorn
Trial completion, Trial completion date: Effects of Analgesics in Cesarean Section Elective (clinicaltrials.gov) - Jan 15, 2020 P4, N=66, Completed, Enrolling by invitation --> Completed Recruiting --> Completed | Trial completion date: Nov 2019 --> Jul 2019
- |||||||||| morphine sulphate / Generic mfg., midazolam hydrochloride / Generic mfg.
Trial primary completion date, Surgery: Combined Epidural Morphine and Midazolam on Postoperative Pain (clinicaltrials.gov) - Jan 13, 2020 P1/2, N=20, Recruiting, Trial completion date: Sep 2019 --> Mar 2020 Trial primary completion date: Dec 2019 --> Dec 2020
- |||||||||| morphine sulphate / Generic mfg., hydromorphone hydrochloride / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date, Head-to-Head, Surgery: Satisfactory Analgesia Minimal Emesis in Day Surgeries (clinicaltrials.gov) - Jan 13, 2020 P=N/A, N=402, Completed, Trial primary completion date: Dec 2019 --> Dec 2020 Active, not recruiting --> Completed | Trial completion date: Oct 2019 --> Mar 2019 | Trial primary completion date: Oct 2019 --> Mar 2019
- |||||||||| morphine sulphate / Generic mfg.
Enrollment change: Neuroimmune Effects of Opioid Administration (clinicaltrials.gov) - Jan 13, 2020 P1, N=10, Recruiting, Active, not recruiting --> Completed | Trial completion date: Oct 2019 --> Mar 2019 | Trial primary completion date: Oct 2019 --> Mar 2019 N=20 --> 10
- |||||||||| morphine sulphate / Generic mfg., ropivacaine / Generic mfg.
Trial completion: CTPVB for Hepatectomy (clinicaltrials.gov) - Jan 2, 2020 P=N/A, N=76, Completed, N=20 --> 10 Recruiting --> Completed
- |||||||||| morphine sulphate / Generic mfg.
Enrollment closed: NOWSHINE: CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome (clinicaltrials.gov) - Dec 24, 2019 P2, N=99, Active, not recruiting, While HFNC oxygen remains a viable treatment option for hospitalized patients who have acute respiratory failure and a DNI and/or DNR order, there is a paucity of high-quality, comparative, effectiveness data to guide the usage of HFNC oxygen compared with other treatments, such as noninvasive ventilation, conventional oxygen, and palliative opioids. Not yet recruiting --> Active, not recruiting
- |||||||||| morphine sulphate / Generic mfg.
Trial completion: Hypnosis in Interventional Electrophysiology (clinicaltrials.gov) - Dec 23, 2019 P=N/A, N=116, Completed, Not yet recruiting --> Active, not recruiting Recruiting --> Completed
- |||||||||| morphine sulphate / Generic mfg.
Enrollment open, Phase classification, Metastases: Cordotomy in Reducing Pain in Patients With Advanced Cancer (clinicaltrials.gov) - Dec 17, 2019 P=N/A, N=42, Recruiting, Active, not recruiting --> Completed Not yet recruiting --> Recruiting | Phase classification: P3 --> PN/A
- |||||||||| morphine sulphate / Generic mfg.
Trial completion, Phase classification, Trial completion date, Trial primary completion date, Surgery: Safety and Efficacy of Intrathecally Administered Magnesium Sulfate (clinicaltrials.gov) - Dec 12, 2019 P=N/A, N=90, Completed, The association of magnesium and ketamine bolus followed by infusion in open bariatric surgery appears to be safe and decreases morphine requirements in the first 24 h compared with both ketamine alone and placebo. Enrolling by invitation --> Completed | Phase classification: P3 --> PN/A | Trial completion date: Jun 2018 --> Jun 2019 | Trial primary completion date: May 2018 --> May 2019
- |||||||||| morphine sulphate / Generic mfg.
Enrollment open, Trial initiation date: Analgesics in the Pre-hospital Setting: Implications on Hemorrhage Tolerance - Morphine (clinicaltrials.gov) - Dec 11, 2019 P4, N=30, Recruiting, Enrolling by invitation --> Completed | Phase classification: P3 --> PN/A | Trial completion date: Jun 2018 --> Jun 2019 | Trial primary completion date: May 2018 --> May 2019 Not yet recruiting --> Recruiting | Initiation date: Jun 2020 --> Nov 2019
- |||||||||| morphine sulphate / Generic mfg.
Trial completion date, Trial primary completion date: A Relation of Morphine-induced Itch and Pain Processing (clinicaltrials.gov) - Dec 4, 2019 P=N/A, N=24, Not yet recruiting, Active, not recruiting --> Completed | Trial completion date: Jun 2020 --> Sep 2019 Trial completion date: Dec 2019 --> Dec 2020 | Trial primary completion date: Dec 2019 --> May 2020
- |||||||||| pethidine / Samaritan
Trial completion: Erector Spinae Plane Block in Scoliotic Adolescents (clinicaltrials.gov) - Dec 3, 2019 P2, N=30, Completed, Not yet recruiting --> Recruiting | Trial completion date: Jun 2021 --> Jun 2022 | Trial primary completion date: Jun 2021 --> Jun 2022 Recruiting --> Completed
- |||||||||| morphine sulphate / Generic mfg., epinephrine / Generic mfg.
Enrollment open, Trial completion date, Trial primary completion date: Surgicel and Analgesic Reservoir (clinicaltrials.gov) - Nov 29, 2019 P2/3, N=90, Recruiting, N=66 --> 0 | Trial completion date: Mar 2021 --> Oct 2019 | Not yet recruiting --> Withdrawn | Trial primary completion date: Jan 2021 --> Oct 2019 Not yet recruiting --> Recruiting | Trial completion date: Jul 2019 --> Dec 2019 | Trial primary completion date: Jul 2019 --> Dec 2019
- |||||||||| ketorolac / Generic mfg., morphine sulphate / Generic mfg., ketamine / Generic mfg.
Trial completion date, Trial primary completion date: ANA01: Anesthetics and Analgesics in Children (clinicaltrials.gov) - Nov 29, 2019 P=N/A, N=120, Recruiting, Not yet recruiting --> Recruiting | Trial completion date: Jul 2019 --> Dec 2019 | Trial primary completion date: Jul 2019 --> Dec 2019 Trial completion date: Sep 2022 --> Sep 2021 | Trial primary completion date: Mar 2020 --> Sep 2020
- |||||||||| morphine sulphate / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Bilateral vs. Unilateral Erector Spinae Plane Block (clinicaltrials.gov) - Nov 25, 2019 P=N/A, N=90, Completed, N=75 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Completed | N=40 --> 90 | Trial primary completion date: Mar 2019 --> Jun 2019
- |||||||||| morphine sulphate / Generic mfg., hydromorphone hydrochloride / Generic mfg.
Trial completion date, Trial primary completion date, Head-to-Head: Spinal Hydromorphone Versus Morphine for Post-Cesarean Delivery Analgesia (clinicaltrials.gov) - Nov 20, 2019 P4, N=126, Not yet recruiting, Not yet recruiting --> Recruiting Trial completion date: Jun 2020 --> Dec 2022 | Trial primary completion date: Jun 2020 --> Dec 2022
- |||||||||| morphine sulphate / Generic mfg., epinephrine / Generic mfg.
Enrollment closed: HAAF: Mechanisms of Hypoglycemia Associated Autonomic Failure (clinicaltrials.gov) - Nov 18, 2019 P2, N=116, Active, not recruiting, Trial completion date: Jun 2020 --> Dec 2022 | Trial primary completion date: Jun 2020 --> Dec 2022 Recruiting --> Active, not recruiting
- |||||||||| morphine sulphate / Generic mfg., ropivacaine / Generic mfg.
Trial completion date, Trial primary completion date, Surgery: TQL-block for Laparoscopic Hemicolectomy (clinicaltrials.gov) - Nov 8, 2019 P4, N=64, Recruiting, Recruiting --> Completed | Trial completion date: Mar 2018 --> May 2019 Trial completion date: Aug 2019 --> Apr 2020 | Trial primary completion date: Aug 2019 --> Mar 2020
- |||||||||| naltrexone / Generic mfg.
Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date: Comparison of Three Opioid Detoxification Treatment Regimens (clinicaltrials.gov) - Nov 6, 2019 P3, N=0, Withdrawn, Trial completion date: Aug 2019 --> Apr 2020 | Trial primary completion date: Aug 2019 --> Mar 2020 N=60 --> 0 | Trial completion date: Apr 2020 --> Oct 2020 | Not yet recruiting --> Withdrawn | Trial primary completion date: Feb 2020 --> Sep 2020
|